Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease

Código QR

Real-life results of switching from preserved to preservative-free artificial tears containing hyaluronate in patients with dry eye disease

Linda Nasser,1 Malgorzata Rozycka,2 Gabriela Gomez Rendon,3 Alejandro Navas4 1Institute for Prevention of Blindness in Nuevo Leon, Monterrey, Mexico; 2Théa Laboratories, Mexico City, Mexico; 3Private practice; 4Cornea department, Institute of Ophthalmology, Conde de Valenciana, Mexico Ci...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nasser L, Rozycka M, Gomez Rendon G, Navas A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Dry eye syndrome ocular surface diseases preservative-free artificial tears benzalkonium chloride-free (BAK-free) Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/043852f778774d9ab063b457d7d48ae0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The use of preservatives in dry eye drops
por: Walsh K, et al.
Publicado: (2019)

Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice
por: Pillunat LE, et al.
Publicado: (2016)

Safety and comfort evaluation of a new formulation of Visine® lubricant eye drops containing HydroBlend™ and GentlePur™
por: Torkildsen G, et al.
Publicado: (2016)

A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease
por: Kuzmanović Elabjer B, et al.
Publicado: (2020)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
por: Alanazi SA, et al.
Publicado: (2019)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate N, et al.
Publicado: (2020)

Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost
por: Erb C, et al.
Publicado: (2021)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
por: Aragona P, et al.
Publicado: (2020)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
por: Pepose JS, et al.
Publicado: (2019)

Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use
por: Molina-Solana P, et al.
Publicado: (2020)

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
por: Uusitalo H, et al.
Publicado: (2016)

Glaucoma therapy: preservative-free for all?
por: Thygesen J
Publicado: (2018)

Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
por: Mylla Boso AL, et al.
Publicado: (2020)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou MA, et al.
Publicado: (2018)

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye
por: Torkildsen G, et al.
Publicado: (2017)

Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations
por: Kaido M, et al.
Publicado: (2017)

Dynamics of tear fluid desiccation on a glass surface: a contribution to tear quality assessment
por: Traipe-Castro,Leonidas, et al.
Publicado: (2014)

Evaluation of Tear Film Urea Level as a Diagnostic Marker of Dry Eye Disease: A Pilot Study
por: Gurunadh Satyanarayana Velamakanni, et al.
Publicado: (2021)

Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye
por: Alanazi SA, et al.
Publicado: (2019)

Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease
por: Mateo Orobia AJ, et al.
Publicado: (2018)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
por: Miyake H, et al.
Publicado: (2016)

Progress in tear microdesiccate analysis by combining various transmitted-light microscope techniques
por: Traipe-Salas,Felipe, et al.
Publicado: (2016)

Stimulating Tear Production: Spotlight on Neurostimulation
por: Yu MD, et al.
Publicado: (2021)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
por: Groß D, et al.
Publicado: (2017)

An assessment of the ocular tear film in patients with thyroid disorders
por: Alanazi SA, et al.
Publicado: (2019)

Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
por: Ng A, et al.
Publicado: (2018)

Effects of Intense Pulsed Light on Tear Film TGF-β and Microbiome in Ocular Rosacea with Dry Eye
por: Sagaser S, et al.
Publicado: (2021)

Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Usefulness of Matrix Metalloproteinase 9 Testing as a Response Prediction Marker
por: Ryu KJ, et al.
Publicado: (2021)

Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose
por: Wallerstein A, et al.
Publicado: (2018)

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution
por: Favuzza E, et al.
Publicado: (2020)

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo J, et al.
Publicado: (2016)

Tear protein analysis in presumed congenital alacrima
por: Yaginuma S, et al.
Publicado: (2018)

The acute effect of a single dose of green tea on the quality and quantity of tears in normal eye subjects
por: Masmali AM, et al.
Publicado: (2019)

Possible association between subtypes of dry eye disease and seasonal variation
por: Ayaki M, et al.
Publicado: (2017)

Investigating the potential benefits of a new artificial tear formulation combining two polymers
por: Simmons PA, et al.
Publicado: (2017)

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
por: Pillunat LE, et al.
Publicado: (2017)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018)

Patient-reported severity of dry eye and quality of life in diabetes
por: Yazdani-Ibn-Taz MK, et al.
Publicado: (2019)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu E, et al.
Publicado: (2020)

Effectiveness Of Polyethylene Cover Versus Polyethylene Cover With Artificial Tear Drop To Prevent Dry Eye In Critically Ill Patients: A Randomized Controlled Clinical Trial
por: Nikseresht T, et al.
Publicado: (2019)